Two separate studies have shown in co-infection experiments with influenza and Staphylococcus aureus, that the induction of type I interferon from the virus increased susceptibility to secondary bacterial pneumonia by directly inhibiting IL-17 production (23, 24). Here, IL17A is linked to bacterial pneumonia.